REAL-WORLD OUTCOMES AMONG AML PATIENTS TREATED WITH DECITABINE OR AZACITIDINE

被引：0
|
作者：
Smith, B. [1 ]
Beach, C. [2 ]
Mahmoud, D. [3 ]
Weber, L. [3 ]
Henk, H. [4 ]
机构：
[1] Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
[2] Hematol Oncol Clin Reserch & Dev, Summitt, NJ USA
[3] Celgene, Global Pricing & Market Access, Summitt, NJ USA
[4] Optum, Eden Prairie, MN USA
来源：
HAEMATOLOGICA | 2013年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P047
引用
收藏
页码：19 / 19
页数：1
相关论文
共 50 条
  • [41] Real-world outcomes of patients with advanced gastric cancer treated with FOLFIRI.
    Fawaz, Ali
    Tilley, Derek
    Karachiwala, Hatim
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 307 - 307
  • [42] Real-world outcomes for 205 patients with chronic lymphocytic leukemia treated with ibrutinib
    Aarup, Kathrine
    Rotbain, Emelie Curovic
    Enggaard, Lisbeth
    Pedersen, Robert Schou
    Bergmann, Olav Jonas
    Thomsen, Rasmus Heje
    Frederiksen, Mikael
    Frederiksen, Henrik
    Nielsen, Tine
    Christiansen, Ilse
    Andersen, Michael Asger
    Niemann, Carsten Utoft
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2020, 105 (05) : 646 - 654
  • [43] Survival and hospitalization among patients with acute myeloid leukemia treated with azacitidine or decitabine in a large managed care population: a real-world, retrospective, claims-based, comparative analysis (Vol 3, 19, 2014)
    Smith, B. Douglas
    Beach, Charles L.
    Mahmoud, Dalia
    Weber, Laura
    Henk, Henry J.
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2014, 3
  • [44] Real-world outcomes among patients with metastatic colorectal cancer treated first line with bevacizumab-awwb.
    Jin, Ran
    Ogbomo, Adesuwa S.
    Accortt, Neil A.
    Lal, Lincy S.
    Bishi, Geetanjali
    Sandschafer, Darcie
    Goldschmidt, Jerome H.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E15581 - E15581
  • [45] REAL-WORLD TREATMENT OUTCOMES AMONG RELAPSED/REFRACTORY PATIENTS WITH MANTLE CELL LYMPHOMA TREATED WITH IBRUTINIB OR ACALABRUTINIB
    Crawford, S.
    Lafeuille, M. H.
    Emond, B.
    Harb, D.
    Voladarsky, R.
    Chen, N.
    Karve, S.
    VALUE IN HEALTH, 2023, 26 (06) : S403 - S403
  • [46] REAL WORLD USE OF AZACITIDINE IN ELDERLY PATIENTS WITH MDS/AML-THE SCOTTISH EXPERIENCE
    Lund, K.
    Drummond, M.
    Eynaud, P.
    Fitzsimons, K.
    Olaiya, A.
    Copland, M.
    HAEMATOLOGICA, 2013, 98 : 309 - 310
  • [47] A real-world study of PIRA among MS patients treated with Ocrelizumab and Alemtuzumab
    Polidoro, Federica
    Zito, Antonio
    Singh-Curry, Victoria
    Nandoskar, Ashwini
    Felongco-sagge, Teresa
    Dela Cruz, Dionisio Johnny
    Dorsey, Rachel
    Muraro, Paolo
    Nicholas, Richard
    Scalfari, Antonio
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 369 - 370
  • [48] Real-World Observational Study of Outcomes for Acute Myeloid Leukemia (AML) in Patients Treated with Glasdegib or Venetoclax in US Community Oncology Practices
    Gajra, Ajeet
    Kish, Jonathan K.
    Russell-Smith, Alexander
    Savill, Kristin M.
    BLOOD, 2022, 140 : 5296 - 5297
  • [49] Real-World Outcomes Among Patients With Early Rapidly Progressive Rheumatoid Arthritis
    Klink, Andrew J.
    Curtice, Tammy G.
    Gupta, Kiran
    Tuell, Kenneth W.
    Szymialis, A. Richard
    Nero, Damion
    Feinberg, Bruce A.
    AMERICAN JOURNAL OF MANAGED CARE, 2019, 25 (10): : E288 - E295
  • [50] TREATMENT PATTERNS AND REAL-WORLD OUTCOMES AMONG PATIENTS WITH EPISODIC MIGRAINE IN CHINA
    Zhao, H.
    Zhang, L.
    Ford, J.
    Li, Z.
    Zhong, S.
    Ye, W.
    Li, J.
    Tockhorn-Heidenreich, A.
    Cotton, S.
    Chen, C.
    VALUE IN HEALTH, 2021, 24 : S171 - S171
12345